Paper37569749
Ivy Leaf Dry Extract EA 575® Has an Inhibitory Effect on the Signalling Cascade of Adenosine Receptor A2B.
Meurer F and 2 others. Int J Mol Sci, 2023. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Ivy Leaf Dry Extract EA 575® Has an Inhibitory Effect on the Signalling Cascade of Adenosine Receptor A2B. Papers, record 37569749. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37569749
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Ivy Leaf Dry Extract EA 575® Has an Inhibitory Effect on the Signalling Cascade of Adenosine Receptor A2B.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Receptor, Adenosine A2B | Major topic |
| Plant Extracts | Major topic |
| Signal Transduction | Major topic |
| Plant Leaves | Major topic |
| Humans | |
| HEK293 Cells | |
| Cyclic AMP | |
| beta-Arrestin 2 | |
| Interleukin-6 |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| H-061.0037 | Engelhard Arzneimittel (Germany) | PubMed |
Source PubMed
References91
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11897989 | Plasma adenosine concentration increases during exercise: a possible contributing factor in exercise-induced bronchoconstriction in asthma. | J Allergy Clin Immunol | 2002 | https://conductscience.org/library/papers/11897989 | PubMed |
| 2 | 9478961 | Adenosine deaminase-deficient mice generated using a two-stage genetic engineering strategy exhibit a combined immunodeficiency. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9478961 | PubMed |
| 3 | 2405250 | Involvement of a NF-kappa B-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines. | Mol Cell Biol | 1990 | https://conductscience.org/library/papers/2405250 | PubMed |
| 4 | 15472138 | Synergy between A2B adenosine receptors and hypoxia in activating human lung fibroblasts. | Am J Respir Cell Mol Biol | 2005 | https://conductscience.org/library/papers/15472138 | PubMed |
| 5 | 11591798 | Adenosine-dependent airway inflammation and hyperresponsiveness in partially adenosine deaminase-deficient mice. | J Immunol | 2001 | https://conductscience.org/library/papers/11591798 | PubMed |
| 6 | 25318478 | Deletion of ADORA2B from myeloid cells dampens lung fibrosis and pulmonary hypertension. | FASEB J | 2015 | https://conductscience.org/library/papers/25318478 | PubMed |
| 7 | 16280366 | Immunomodulatory impact of the A2A adenosine receptor on the profile of chemokines produced by neutrophils. | FASEB J | 2006 | https://conductscience.org/library/papers/16280366 | PubMed |
| 8 | 16236847 | Airway and systemic inflammation and decline in lung function in patients with COPD. | Chest | 2005 | https://conductscience.org/library/papers/16236847 | PubMed |
| 9 | 10899903 | Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction. | J Exp Med | 2000 | https://conductscience.org/library/papers/10899903 | PubMed |
| 10 | 2885756 | Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. | Nature | 1987 | https://conductscience.org/library/papers/2885756 | PubMed |
| 11 | 29106905 | Characterisation of endogenous A2A and A2B receptor-mediated cyclic AMP responses in HEK 293 cells using the GloSensor™ biosensor: Evidence for an allosteric mechanism of action for the A2B-selective antagonist PSB 603. | Biochem Pharmacol | 2018 | https://conductscience.org/library/papers/29106905 | PubMed |
| 12 | 24511476 | The Effect of Adenosine A2A and A2B Antagonists on Tracheal Responsiveness, Serum Levels of Cytokines and Lung Inflammation in Guinea Pig Model of Asthma. | Adv Pharm Bull | 2014 | https://conductscience.org/library/papers/24511476 | PubMed |
| 13 | 31832428 | Efficacy of two dosing schemes of a liquid containing ivy leaves dry extract EA 575 versus placebo in the treatment of acute bronchitis in adults. | ERJ Open Res | 2019 | https://conductscience.org/library/papers/31832428 | PubMed |
| 14 | 21496101 | Enhanced IL-6 transcriptional response to adenosine receptor ligands in horses with lower airway inflammation. | Equine Vet J | 2012 | https://conductscience.org/library/papers/21496101 | PubMed |
| 15 | 1374772 | Cytokines in symptomatic asthma airways. | J Allergy Clin Immunol | 1992 | https://conductscience.org/library/papers/1374772 | PubMed |
| 16 | 19278262 | Alpha-hederin, but not hederacoside C and hederagenin from Hedera helix, affects the binding behavior, dynamics, and regulation of beta 2-adrenergic receptors. | Biochemistry | 2009 | https://conductscience.org/library/papers/19278262 | PubMed |
| 17 | 23136556 | Role of IL-6 in asthma and other inflammatory pulmonary diseases. | Int J Biol Sci | 2012 | https://conductscience.org/library/papers/23136556 | PubMed |
| 18 | 1583242 | Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. | J Allergy Clin Immunol | 1992 | https://conductscience.org/library/papers/1583242 | PubMed |
| 19 | 20880874 | Sputum IL-6 concentrations in severe asthma and its relationship with FEV1. | Thorax | 2011 | https://conductscience.org/library/papers/20880874 | PubMed |
| 20 | 31051404 | The A2A receptor agonist CGS 21680 has beneficial and adverse effects on disease development in a humanised mouse model of graft-versus-host disease. | Int Immunopharmacol | 2019 | https://conductscience.org/library/papers/31051404 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42739377 | From Traditional Remedy to Evidence-Based Phytotherapeutic Agent: Hedera helix L. in Respiratory Medicine. | Plants (Basel) | 2026 | https://conductscience.org/library/papers/42739377 | PubMed |
| 42196994 | A Review of the Properties of Clinically Evaluated Plant-Derived Agents in the Treatment of Respiratory Infections. | Nutrients | 2026 | https://conductscience.org/library/papers/42196994 | PubMed |
| 40722746 | Efficacy of EA575 as an Antitussive and Mucoactive Agent in Preclinical In Vivo Models. | Biomedicines | 2025 | https://conductscience.org/library/papers/40722746 | PubMed |
| 40574085 | Ivy Leaf Dry Extract EA 575® Is a Potent Immunomodulator Acting on Dendritic Cells. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40574085 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37569749
GET https://conductscience.org/api/papers/v1/37569749/references?page=2